Search Results

You are looking at 1 - 2 of 2 items for

  • Author: N. A. PLUMMER x
  • Refine by access: All content x
Clear All Modify Search
N. A. PLUMMER
Search for other papers by N. A. PLUMMER in
Google Scholar
PubMed
Close
and
A. J. THODY
Search for other papers by A. J. THODY in
Google Scholar
PubMed
Close

In a recent radioimmunoassay for human β-melanocyte-stimulating hormone (βh-MSH) (Thody & Plummer, 1973) the dextran-coated charcoal technique (Herbert, Lau, Gottlieb & Bleicher, 1965) was used for the separation of antibody-bound and free hormone. We have now examined several other methods of separation.

Details of the antiserum and iodination of synthetic βh-MSH have been described (Thody & Plummer, 1973). Tubes were set up containing 25 pg 125I-labelled βh-MSH and diluted antiserum in 210 μl diluent buffer (0·05 m-phosphate buffer, pH 7·4 containing 0·5% human serum albumin and 0·02% thiomersal (Merthiolate)). The final dilution of antiserum was 1:8250, sufficient to bind approximately 50–70% of 125I-labelled βh-MSH (Thody & Plummer, 1973). Blanks containing no antiserum were set up in parallel. After incubation for 24 h at 4 °C antibody-bound and free 125I-labelled βh-MSH were separated. For separation by the second

Restricted access
A. J. THODY
Search for other papers by A. J. THODY in
Google Scholar
PubMed
Close
and
N. A. PLUMMER
Search for other papers by N. A. PLUMMER in
Google Scholar
PubMed
Close

SUMMARY

A method is described for the radioimmunoassay of β-melanocyte-stimulating hormone (β-MSH) in human plasma. It was capable of detecting 20–30 pg β-MSH and was unaffected by the presence of α-MSH and human adrenocorticotrophic hormone. However, cross-reactivity did occur with β-glutamyl MSH (porcine).

A simple technique employing porous glass (Florisil) was used to extract β-MSH from plasma. In normal male subjects plasma β-MSH levels ranged from 21 to 133 pg/ml. In patients receiving cortisol therapy for Addison's disease slightly elevated levels were found. Much higher levels were found in patients who had undergone bilateral adrenalectomy as treatment for Cushing's disease.

Restricted access